TY - JOUR AU - Arndt, V. PY - 2007 DA - 2007// TI - Up-to-date monitoring of childhood cancer long-term survival in Europe: tumours of the sympathetic nervous system, retinoblastoma, renal and bone tumours, and soft tissue sarcomas JO - Ann Oncol VL - 18 UR - https://doi.org/10.1093/annonc/mdm189 DO - 10.1093/annonc/mdm189 ID - Arndt2007 ER - TY - JOUR AU - Collins, M. PY - 2013 DA - 2013// TI - Benefits and adverse events in younger versus older patients receiving neoadjuvant chemotherapy for osteosarcoma: findings from a meta-analysis JO - J Clin Oncol VL - 31 UR - https://doi.org/10.1200/JCO.2012.43.8598 DO - 10.1200/JCO.2012.43.8598 ID - Collins2013 ER - TY - JOUR AU - Mirabello, L. AU - Troisi, R. J. AU - Savage, S. A. PY - 2009 DA - 2009// TI - International osteosarcoma incidence patterns in children and adolescents, middle ages and elderly persons JO - Int J Cancer VL - 125 UR - https://doi.org/10.1002/ijc.24320 DO - 10.1002/ijc.24320 ID - Mirabello2009 ER - TY - JOUR AU - Kansara, M. PY - 2014 DA - 2014// TI - Translational biology of osteosarcoma JO - Nat Rev Cancer VL - 14 UR - https://doi.org/10.1038/nrc3838 DO - 10.1038/nrc3838 ID - Kansara2014 ER - TY - JOUR AU - Bousquet, M. PY - 2016 DA - 2016// TI - Whole-exome sequencing in osteosarcoma reveals important heterogeneity of genetic alterations JO - Ann Oncol VL - 27 UR - https://doi.org/10.1093/annonc/mdw009 DO - 10.1093/annonc/mdw009 ID - Bousquet2016 ER - TY - JOUR AU - Subbiah, V. PY - 2019 DA - 2019// TI - Alpha particle radium 223 dichloride in high-risk osteosarcoma: a phase I dose escalation trial JO - Clin Cancer Res VL - 25 UR - https://doi.org/10.1158/1078-0432.CCR-18-3964 DO - 10.1158/1078-0432.CCR-18-3964 ID - Subbiah2019 ER - TY - JOUR AU - Cortini, M. AU - Avnet, S. AU - Baldini, N. PY - 2017 DA - 2017// TI - Mesenchymal stroma: role in osteosarcoma progression JO - Cancer Lett VL - 405 UR - https://doi.org/10.1016/j.canlet.2017.07.024 DO - 10.1016/j.canlet.2017.07.024 ID - Cortini2017 ER - TY - JOUR AU - Scott, M. C. PY - 2018 DA - 2018// TI - Comparative transcriptome analysis quantifies immune cell transcript levels, metastatic progression, and survival in osteosarcoma JO - Cancer Res VL - 78 UR - https://doi.org/10.1158/0008-5472.CAN-17-0576 DO - 10.1158/0008-5472.CAN-17-0576 ID - Scott2018 ER - TY - JOUR AU - Barrett, T. PY - 2012 DA - 2012// TI - NCBI GEO: archive for functional genomics data sets—update JO - Nucleic Acids Res VL - 41 UR - https://doi.org/10.1093/nar/gks1193 DO - 10.1093/nar/gks1193 ID - Barrett2012 ER - TY - JOUR AU - Ritchie, M. E. PY - 2015 DA - 2015// TI - limma powers differential expression analyses for RNA-sequencing and microarray studies JO - Nucleic Acids Res VL - 43 UR - https://doi.org/10.1093/nar/gkv007 DO - 10.1093/nar/gkv007 ID - Ritchie2015 ER - TY - JOUR AU - Langfelder, P. AU - Horvath, S. PY - 2008 DA - 2008// TI - WGCNA: an R package for weighted correlation network analysis JO - BMC Bioinformatics VL - 9 UR - https://doi.org/10.1186/1471-2105-9-559 DO - 10.1186/1471-2105-9-559 ID - Langfelder2008 ER - TY - JOUR AU - Langfelder, P. AU - Horvath, S. PY - 2012 DA - 2012// TI - Fast R functions for robust correlations and hierarchical clustering JO - J Stat Softw VL - 46 UR - https://doi.org/10.18637/jss.v046.i11 DO - 10.18637/jss.v046.i11 ID - Langfelder2012 ER - TY - JOUR PY - 2019 DA - 2019// TI - The gene ontology resource: 20 years and still going strong JO - Nucleic Acids Res VL - 47 UR - https://doi.org/10.1093/nar/gky1055 DO - 10.1093/nar/gky1055 ID - ref13 ER - TY - JOUR AU - Yu, G. AU - Wang, L. G. AU - Han, Y. AU - He, Q. Y. PY - 2012 DA - 2012// TI - clusterProfiler: an R package for comparing biological themes among gene clusters JO - OMICS VL - 16 UR - https://doi.org/10.1089/omi.2011.0118 DO - 10.1089/omi.2011.0118 ID - Yu2012 ER - TY - JOUR AU - Mootha, V. K. PY - 2003 DA - 2003// TI - PGC-1α-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes JO - Nat Genet VL - 34 UR - https://doi.org/10.1038/ng1180 DO - 10.1038/ng1180 ID - Mootha2003 ER - TY - JOUR AU - Subramanian, A. PY - 2005 DA - 2005// JO - Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. VL - 102 ID - Subramanian2005 ER - TY - JOUR AU - Liberzon, A. PY - 2015 DA - 2015// TI - The molecular signatures database hallmark gene set collection JO - Cell Syst VL - 1 UR - https://doi.org/10.1016/j.cels.2015.12.004 DO - 10.1016/j.cels.2015.12.004 ID - Liberzon2015 ER - TY - JOUR AU - Fabregat, A. PY - 2018 DA - 2018// TI - The reactome pathway knowledgebase JO - Nucleic Acids Res VL - 46 UR - https://doi.org/10.1093/nar/gkx1132 DO - 10.1093/nar/gkx1132 ID - Fabregat2018 ER - TY - JOUR AU - Whelan, J. S. AU - Davis, L. E. PY - 2018 DA - 2018// TI - Osteosarcoma, chondrosarcoma, and chordoma JO - J Clin Oncol VL - 36 UR - https://doi.org/10.1200/JCO.2017.75.1743 DO - 10.1200/JCO.2017.75.1743 ID - Whelan2018 ER - TY - JOUR AU - Bielack, S. PY - 2009 DA - 2009// TI - Osteosarcoma: ESMO clinical recommendations for diagnosis, treatment and follow-up JO - Ann Oncol VL - 20 UR - https://doi.org/10.1093/annonc/mdp154 DO - 10.1093/annonc/mdp154 ID - Bielack2009 ER - TY - JOUR AU - Smeland, S. PY - 2019 DA - 2019// TI - Survival and prognosis with osteosarcoma: outcomes in more than 2000 patients in the EURAMOS-1 (European and American Osteosarcoma Study) cohort JO - Eur J Cancer VL - 109 UR - https://doi.org/10.1016/j.ejca.2018.11.027 DO - 10.1016/j.ejca.2018.11.027 ID - Smeland2019 ER - TY - JOUR AU - Wunder, J. S. PY - 2007 DA - 2007// TI - Opportunities for improving the therapeutic ratio for patients with sarcoma JO - Lancet Oncol VL - 8 UR - https://doi.org/10.1016/S1470-2045(07)70169-9 DO - 10.1016/S1470-2045(07)70169-9 ID - Wunder2007 ER - TY - JOUR AU - Piperno-Neumann, S. PY - 2016 DA - 2016// TI - Zoledronate in combination with chemotherapy and surgery to treat osteosarcoma (OS2006): a randomised, multicentre, open-label, phase 3 trial JO - Lancet Oncol VL - 17 UR - https://doi.org/10.1016/S1470-2045(16)30096-1 DO - 10.1016/S1470-2045(16)30096-1 ID - Piperno-Neumann2016 ER - TY - JOUR AU - Otto, T. AU - Sicinski, P. PY - 2017 DA - 2017// TI - Cell cycle proteins as promising targets in cancer therapy JO - Nat Rev Cancer VL - 17 UR - https://doi.org/10.1038/nrc.2016.138 DO - 10.1038/nrc.2016.138 ID - Otto2017 ER - TY - JOUR AU - Kohrman, A. Q. AU - Matus, D. Q. PY - 2017 DA - 2017// TI - Divide or conquer: cell cycle regulation of invasive behavior JO - Trends Cell Biol VL - 27 UR - https://doi.org/10.1016/j.tcb.2016.08.003 DO - 10.1016/j.tcb.2016.08.003 ID - Kohrman2017 ER - TY - JOUR AU - Gonzalez, H. AU - Hagerling, C. AU - Werb, Z. PY - 2018 DA - 2018// TI - Roles of the immune system in cancer: from tumor initiation to metastatic progression JO - Genes Dev VL - 32 UR - https://doi.org/10.1101/gad.314617.118 DO - 10.1101/gad.314617.118 ID - Gonzalez2018 ER - TY - JOUR AU - Janssen, L. M. E. PY - 2017 DA - 2017// TI - The immune system in cancer metastasis: friend or foe? JO - J Immunother Cancer VL - 5 UR - https://doi.org/10.1186/s40425-017-0283-9 DO - 10.1186/s40425-017-0283-9 ID - Janssen2017 ER - TY - JOUR AU - Wu, B. PY - 2018 DA - 2018// TI - The arachidonic acid metabolism protein-protein interaction network and its expression pattern in esophageal diseases JO - Am J Transl Res VL - 10 ID - Wu2018 ER - TY - JOUR AU - Shi, Q. PY - 2019 DA - 2019// TI - Integrative analysis identifies DNMTs against immune-infiltrating neutrophils and dendritic cells in colorectal cancer JO - Epigenetics VL - 14 UR - https://doi.org/10.1080/15592294.2019.1588684 DO - 10.1080/15592294.2019.1588684 ID - Shi2019 ER - TY - JOUR AU - Haeggstrom, J. Z. PY - 2018 DA - 2018// TI - Leukotriene biosynthetic enzymes as therapeutic targets JO - J Clin Invest VL - 128 UR - https://doi.org/10.1172/JCI97945 DO - 10.1172/JCI97945 ID - Haeggstrom2018 ER - TY - JOUR AU - Abelin, J. G. PY - 2019 DA - 2019// TI - Defining HLA-II ligand processing and binding rules with mass spectrometry enhances cancer epitope prediction JO - Immunity VL - 51 UR - https://doi.org/10.1016/j.immuni.2019.08.012 DO - 10.1016/j.immuni.2019.08.012 ID - Abelin2019 ER - TY - JOUR AU - Aissani, B. PY - 2014 DA - 2014// TI - SNP screening of central MHC-identified HLA-DMB as a candidate susceptibility gene for HIV-related Kaposi’s sarcoma JO - Genes Immun VL - 15 UR - https://doi.org/10.1038/gene.2014.42 DO - 10.1038/gene.2014.42 ID - Aissani2014 ER - TY - JOUR AU - Sun, Z. PY - 2016 DA - 2016// TI - Major histocompatibility complex class II HLA-DRalpha is downregulated by Kaposi’s sarcoma-associated herpesvirus-encoded lytic transactivator RTA and MARCH8 JO - J Virol VL - 90 UR - https://doi.org/10.1128/JVI.01079-16 DO - 10.1128/JVI.01079-16 ID - Sun2016 ER - TY - JOUR AU - Yokoyama, J. S. PY - 2016 DA - 2016// TI - Association between genetic traits for immune-mediated diseases and Alzheimer disease JO - JAMA Neurol VL - 73 UR - https://doi.org/10.1001/jamaneurol.2016.0150 DO - 10.1001/jamaneurol.2016.0150 ID - Yokoyama2016 ER - TY - JOUR AU - Callahan, M. J. PY - 2008 DA - 2008// TI - Increased HLA-DMB expression in the tumor epithelium is associated with increased CTL infiltration and improved prognosis in advanced-stage serous ovarian cancer JO - Clin Cancer Res VL - 14 UR - https://doi.org/10.1158/1078-0432.CCR-08-0479 DO - 10.1158/1078-0432.CCR-08-0479 ID - Callahan2008 ER - TY - JOUR AU - Brown, P. J. PY - 2016 DA - 2016// TI - FOXP1 suppresses immune response signatures and MHC class II expression in activated B-cell-like diffuse large B-cell lymphomas JO - Leukemia VL - 30 UR - https://doi.org/10.1038/leu.2015.299 DO - 10.1038/leu.2015.299 ID - Brown2016 ER - TY - JOUR AU - Kongkham, P. N. PY - 2008 DA - 2008// TI - An epigenetic genome-wide screen identifies SPINT2 as a novel tumor suppressor gene in pediatric medulloblastoma JO - Cancer Res VL - 68 UR - https://doi.org/10.1158/0008-5472.CAN-08-2169 DO - 10.1158/0008-5472.CAN-08-2169 ID - Kongkham2008 ER - TY - JOUR AU - Roversi, F. M. AU - Olalla Saad, S. T. AU - Machado-Neto, J. A. PY - 2018 DA - 2018// TI - Serine peptidase inhibitor Kunitz type 2 (SPINT2) in cancer development and progression JO - Biomed Pharmacother VL - 101 UR - https://doi.org/10.1016/j.biopha.2018.02.100 DO - 10.1016/j.biopha.2018.02.100 ID - Roversi2018 ER -